EP2692858A4 - Procédé de fabrication d'un modèle de peau artificiel, et modèle de peau artificiel - Google Patents

Procédé de fabrication d'un modèle de peau artificiel, et modèle de peau artificiel

Info

Publication number
EP2692858A4
EP2692858A4 EP12764146.2A EP12764146A EP2692858A4 EP 2692858 A4 EP2692858 A4 EP 2692858A4 EP 12764146 A EP12764146 A EP 12764146A EP 2692858 A4 EP2692858 A4 EP 2692858A4
Authority
EP
European Patent Office
Prior art keywords
artificial skin
skin model
manufacturing
manufacturing artificial
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP12764146.2A
Other languages
German (de)
English (en)
Other versions
EP2692858B1 (fr
EP2692858A1 (fr
Inventor
Mitsuru Akashi
Michiya Matsusaki
Takeshi Sakura
Koji Hashimoto
Yuji Shirakata
Satoshi Hirakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
University of Osaka NUC
Original Assignee
Osaka University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka University NUC filed Critical Osaka University NUC
Publication of EP2692858A1 publication Critical patent/EP2692858A1/fr
Publication of EP2692858A4 publication Critical patent/EP2692858A4/fr
Application granted granted Critical
Publication of EP2692858B1 publication Critical patent/EP2692858B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0697Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698Skin equivalents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/09Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/11Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1192Lymphatic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/28Vascular endothelial cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/04Screening or testing on artificial tissues
    • C12N2503/06Screening or testing on artificial skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/52Fibronectin; Laminin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/54Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP12764146.2A 2011-03-29 2012-03-29 Procédé de fabrication d'un modèle de peau artificiel, et modèle de peau artificiel Not-in-force EP2692858B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011072207A JP2012205516A (ja) 2011-03-29 2011-03-29 人工皮膚モデルの製造方法、及び人工皮膚モデル
PCT/JP2012/058329 WO2012133629A1 (fr) 2011-03-29 2012-03-29 Procédé de fabrication d'un modèle de peau artificiel, et modèle de peau artificiel

Publications (3)

Publication Number Publication Date
EP2692858A1 EP2692858A1 (fr) 2014-02-05
EP2692858A4 true EP2692858A4 (fr) 2014-11-05
EP2692858B1 EP2692858B1 (fr) 2017-06-14

Family

ID=46931331

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12764146.2A Not-in-force EP2692858B1 (fr) 2011-03-29 2012-03-29 Procédé de fabrication d'un modèle de peau artificiel, et modèle de peau artificiel

Country Status (4)

Country Link
US (1) US10073085B2 (fr)
EP (1) EP2692858B1 (fr)
JP (1) JP2012205516A (fr)
WO (1) WO2012133629A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012205516A (ja) 2011-03-29 2012-10-25 Osaka Univ 人工皮膚モデルの製造方法、及び人工皮膚モデル
US20150250925A1 (en) * 2012-09-04 2015-09-10 Biomedical Technology Hybrid Co., Ltd. Artificial skin tissue, artificial skin model and manufacturing method therefor
JP6288691B2 (ja) * 2013-05-20 2018-03-07 国立大学法人 東京大学 胚様体に対する空間分化誘導制御方法及びその装置
CN105705626B (zh) 2013-10-29 2018-11-16 学校法人北里研究所 细胞或组织的玻璃化冷冻保存用工具
WO2015072164A1 (fr) * 2013-11-14 2015-05-21 国立大学法人大阪大学 Cellule revêtue d'un film de revêtement comprenant du collagène et son procédé de production
JP6674686B2 (ja) * 2014-08-22 2020-04-01 国立大学法人大阪大学 被覆細胞、その製造方法及び被覆細胞を用いた三次元組織体の製造方法
JP6619345B2 (ja) 2014-09-23 2019-12-11 国立大学法人 東京大学 人工三次元組織の製造方法、人工三次元組織灌流デバイス、人工三次元組織を用いた薬剤評価方法
US10799615B2 (en) 2014-12-08 2020-10-13 Osaka University Artificial tissue and method for producing same
US9625449B2 (en) 2014-12-23 2017-04-18 Colgate-Palmolive Company Determining the bioavailability of zinc (II) ions
US9435745B2 (en) 2014-12-23 2016-09-06 Colgate-Palmolive Company Measuring the rate of release of metal ions
US9354219B1 (en) 2014-12-23 2016-05-31 Colgate-Palmolive Company Detecting stannous ions
WO2017126532A1 (fr) * 2016-01-20 2017-07-27 国立大学法人東京大学 Tissu tridimensionnel artificiel et son procédé de fabrication, dispositif de perfusion pour le tissu tridimensionnel artificiel, et procédé d'évaluation de médicaments utilisant le tissu tridimensionnel artificiel
EP3421588B1 (fr) * 2016-02-22 2024-04-10 Osaka University Procédé de production de tissu cellulaire tridimensionnel
EP3447143A4 (fr) * 2016-04-19 2019-11-20 Toppan Printing Co., Ltd. Procédé d'évaluation de médicament anticancéreux
JPWO2017221870A1 (ja) * 2016-06-21 2019-04-11 株式会社オーガンテクノロジーズ 毛包、皮脂腺、および毛穴を有する人工皮膚の製造方法
US20190195753A1 (en) * 2016-08-10 2019-06-27 Shiseido Company, Ltd. Transparent skin sample
KR102288612B1 (ko) 2017-06-12 2021-08-11 미쓰비시 세이시 가부시키가이샤 세포 또는 조직의 동결 보존용 지그
WO2019143498A1 (fr) * 2018-01-22 2019-07-25 ClearIt, LLC Procédés et compositions pour la simulation du compartiment dermique
JP6945487B2 (ja) 2018-04-26 2021-10-06 三菱製紙株式会社 細胞又は組織の凍結保存液
JP2022514758A (ja) 2018-12-19 2022-02-15 クリアイット エルエルシー 印加電場を用いた入れ墨除去システム及び方法
JP7144380B2 (ja) 2019-08-23 2022-09-29 三菱製紙株式会社 細胞又は組織の凍結保存用治具
EP4023289A4 (fr) 2019-08-29 2023-06-14 National University Corporation Ehime University Procédé de production de tissu cultivé, et préparation pour application externe
US11213467B2 (en) 2019-11-07 2022-01-04 Amyris, Inc. Compositions and methods for delivering cannabinoids to skin
LU502391B1 (en) 2022-06-28 2024-01-09 Univerza V Mariboru A complex in vitro model of human skin, a process for preparation and use thereof
JP7471579B1 (ja) * 2023-04-28 2024-04-22 ティシューバイネット株式会社 立体細胞構造体を製造する方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207540A1 (en) * 2006-03-02 2007-09-06 Osaka University Method of producing three-dimensional tissue and method of producing extracellular matrix used in the same
WO2009118283A1 (fr) * 2008-03-28 2009-10-01 Technische Universität Berlin Procédés pour produire des microfollicules capillaires et des papilles de novo et leur utilisation pour des essais in vitro et des implantations in vivo

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612939B1 (fr) 1987-03-26 1989-06-23 Cird Equivalent de peau
FI924773L (fi) * 1990-04-24 1992-10-21 Mark Eisenberg Kompositionssubstituter av levande hud
US5654135A (en) 1990-10-02 1997-08-05 Imedex, Societe Anonyme Biomaterial based on collagen and its application
FR2667246A1 (fr) 1990-10-02 1992-04-03 Imedex Biomateriau a base de collagene et des applications.
WO2003093418A2 (fr) * 2002-04-30 2003-11-13 Stratech Corporation Keratinocytes exprimant des facteurs de croissance angiogeniques exogenes
FR2847269B1 (fr) 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
CN1929878A (zh) 2004-03-11 2007-03-14 阿如布勒斯特有限公司 活体组织片及其制作方法、以及应用该片的移植方法
JP4398290B2 (ja) 2004-03-23 2010-01-13 日水製薬株式会社 ヒト上皮細胞培養用培地
DE102006006461A1 (de) 2006-02-10 2007-08-23 Phenion Gmbh & Co. Kg Hautmodell mit dendritischen Zellen
JP5130376B2 (ja) 2008-11-11 2013-01-30 独立行政法人科学技術振興機構 三次元細胞培養体の生体シグナルの検出方法及び検出キット
JP2010172247A (ja) 2009-01-29 2010-08-12 Kitasato Institute 積層型高密度培養人工組織の製造方法及び積層型高密度培養人工組織
JP5458259B2 (ja) 2009-06-25 2014-04-02 富士フイルム株式会社 細胞積層体
JP5717253B2 (ja) 2009-08-02 2015-05-13 学校法人東京女子医科大学 膵島細胞シート、製造方法及びその利用方法
US8409603B2 (en) 2009-10-01 2013-04-02 University Of South Carolina Compositions and methods for tissue engineering, tissue regeneration and wound healing
JP5850419B2 (ja) 2010-11-11 2016-02-03 国立大学法人大阪大学 細胞の三次元構造体、及び、これを製造する方法
JP2012205516A (ja) 2011-03-29 2012-10-25 Osaka Univ 人工皮膚モデルの製造方法、及び人工皮膚モデル
US20150250925A1 (en) 2012-09-04 2015-09-10 Biomedical Technology Hybrid Co., Ltd. Artificial skin tissue, artificial skin model and manufacturing method therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207540A1 (en) * 2006-03-02 2007-09-06 Osaka University Method of producing three-dimensional tissue and method of producing extracellular matrix used in the same
WO2009118283A1 (fr) * 2008-03-28 2009-10-01 Technische Universität Berlin Procédés pour produire des microfollicules capillaires et des papilles de novo et leur utilisation pour des essais in vitro et des implantations in vivo

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CHONG ET AL: "Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 3, no. 3, 14 April 2007 (2007-04-14), pages 321 - 330, XP022039925, ISSN: 1742-7061, DOI: 10.1016/J.ACTBIO.2007.01.002 *
E BELL ET AL: "Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness", SCIENCE, vol. 211, no. 4486, 6 March 1981 (1981-03-06), pages 1052 - 1054, XP055092741, ISSN: 0036-8075, DOI: 10.1126/science.7008197 *
I. V. YANNAS ET AL: "Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 86, no. 3, 1 February 1989 (1989-02-01), pages 933 - 937, XP055092773, ISSN: 0027-8424, DOI: 10.1073/pnas.86.3.933 *
LAURE GIBOT ET AL: "A Preexisting Microvascular Network Benefits In Vivo Revascularization of a Microvascularized Tissue-Engineered Skin Substitute", TISSUE ENGINEERING PART A, vol. 16, no. 10, 1 October 2010 (2010-10-01), pages 3199 - 3206, XP055092770, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2010.0189 *
LEE KWANG HOON: "Tissue-engineered human living skin substitutes: Development and clinical application", YONSEI MEDICAL JOURNAL, YONSEI UNIVERSITY, KI, vol. 41, no. 6, 1 December 2000 (2000-12-01), pages 774 - 779, XP002198352, ISSN: 0513-5796 *
PRIYA S G ET AL: "Skin tissue engineering for tissue repair and regeneration", TISSUE ENGINEERING PART B-REVIEWS, MARY ANN LIEBERT, INC. PUBLISHERS, US, vol. 14, no. 1, 10 March 2008 (2008-03-10), pages 105 - 118, XP002574141, ISSN: 1937-3368, [retrieved on 20080304], DOI: 10.1089/TEB.2007.0318 *
See also references of WO2012133629A1 *
WILKINS LEON M ET AL: "Development of a bilayered living skin construct for clinical applications", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 43, no. 8, 5 April 1994 (1994-04-05), pages 747 - 756, XP002563453, ISSN: 0006-3592, [retrieved on 20040219], DOI: 10.1002/BIT.260430809 *

Also Published As

Publication number Publication date
US10073085B2 (en) 2018-09-11
EP2692858B1 (fr) 2017-06-14
EP2692858A1 (fr) 2014-02-05
WO2012133629A1 (fr) 2012-10-04
US20140024010A1 (en) 2014-01-23
JP2012205516A (ja) 2012-10-25

Similar Documents

Publication Publication Date Title
EP2692858A4 (fr) Procédé de fabrication d'un modèle de peau artificiel, et modèle de peau artificiel
EP2837796A4 (fr) Procédé de fabrication d'aubes de turbine accouplées et aubes de turbine accouplées
EP2718832A4 (fr) Procédé et logiciel d'autorisation groupée
EP2934404A4 (fr) Stratifié élastique et procédé de fabrication d'un stratifié élastique.
EP2715128A4 (fr) Pale d'éolienne et procédé de fabrication afférent
EP2675417A4 (fr) Harnais gonflable et procédé de positionnement d'un patient
EP2658805A4 (fr) Procédé et agencement d'ascenseur
EP2701229A4 (fr) Procédé et dispositif de fabrication d'accumulateur
EP2740348A4 (fr) Procédé de culture de plantes et équipement de culture de plantes
EP2695314A4 (fr) Noeud b évolué et procédé de configuration de porteuse d'extension
EP2716662A4 (fr) Hydrogel et son procédé de fabrication
EP2713961A4 (fr) Implant embolique et son procédé d'utilisation
EP2865521A4 (fr) Procédé de fabrication d'un stratifié, stratifié et article
EP2692783A4 (fr) Pré-imprégné et son procédé de fabrication
CO6890081A2 (es) Método para producir un cepillo dental, y cepillo dental
IL229317A0 (en) System and method for determining sleep and sleep stages of a person
EP2829235A4 (fr) Procédé de fabrication d'un filet de correction cardiaque
EP2742999A4 (fr) Procédé de fabrication d'un catalyseur redox et utilisation d'un catalyseur redox
EP2548588A4 (fr) Tuteur tridimensionnel artificiel et son procédé de fabrication
EP2772308A4 (fr) Catalyseur d'hydrogénation et procédé de production associé
EP2716336A4 (fr) Puzzle et son procédé de fabrication
EP2754430A4 (fr) Contenant médical et procédé de fabrication d'un contenant médical
EP2695972A4 (fr) Stratifié et procédé de fabrication d'un stratifié
EP2525475A4 (fr) Structure de stator et procédé de fabrication d'un stator
EP2634374A4 (fr) Turbine et procédé de fabrication d'une turbine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131029

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602012033445

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: C12N0005070000

Ipc: C12N0005071000

A4 Supplementary search report drawn up and despatched

Effective date: 20141002

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/071 20100101AFI20140926BHEP

Ipc: G01N 33/50 20060101ALI20140926BHEP

Ipc: C12Q 1/02 20060101ALI20140926BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TORAY INDUSTRIES, INC.

Owner name: OSAKA UNIVERSITY

17Q First examination report despatched

Effective date: 20160202

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20161102

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

INTC Intention to grant announced (deleted)
GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

INTG Intention to grant announced

Effective date: 20170504

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 900973

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170615

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012033445

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170614

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170915

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170914

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 900973

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170914

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171014

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012033445

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

26N No opposition filed

Effective date: 20180315

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180331

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20120329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170614

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602012033445

Country of ref document: DE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230208

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230213

Year of fee payment: 12

Ref country code: GB

Payment date: 20230202

Year of fee payment: 12

Ref country code: DE

Payment date: 20230131

Year of fee payment: 12

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230515

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602012033445

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20240329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20241001

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240329

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240331

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20241001

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240329